Cancer treatment has become increasingly personalised in recent years; the idea of “the same treatment for every patient” is gradually being replaced by approaches shaped around the characteristics of the disease and the individual. One of the most important tools in this shift is genetic testing. In cancer, genetic testing aims to examine the genetic characteristics of the disease, and sometimes of the individual, to reveal information that can help guide treatment.
However, the term “genetic test” is often assumed to refer to a single thing, when in fact oncology involves several different types of test that serve different purposes. This article covers, at a general and informative level, what genetic testing in cancer is, what types exist, and how it can help guide treatment. The content here is not a substitute for diagnosis, treatment recommendations or clinical examination; only a physician can determine which test is appropriate for you.
The Basic Principle of Genetic Testing in Cancer
At its core, cancer is a disease associated with changes in the genetic makeup of cells. These changes can lead to a cell dividing in an uncontrolled way. The basic principle behind genetic testing is to examine these changes in order to understand the behaviour of the disease and to help identify treatment options that may target them.
The value of this approach lies in the fact that certain genetic changes can be associated with the likelihood of responding to specific treatments. In other words, knowing the genetic profile of a cancer can sometimes help guide the physician as to which treatment may be more suitable for that particular cancer. For this reason, genetic testing has become an important part of the personalised approach in modern oncology. However, the results of these tests do not always directly change treatment; interpreting them requires specialist expertise.
The Difference Between Hereditary (Germline) and Tumour (Somatic) Testing
The key to understanding genetic testing in cancer lies in the distinction between two main types of test. Hereditary, or germline, tests examine a person’s inherited genetic characteristics, present in every cell of the body from birth. These tests can be used to assess inherited changes that may predispose a person to developing cancer, and the information they provide can also be relevant to family members.
Tumour, or somatic, tests examine genetic changes that have developed later, within the cancer cells themselves. These changes are not found in the person’s other cells; they are specific to the tumour and are mostly assessed for the purpose of guiding treatment. The two tests seek answers to different questions: a germline test asks whether a predisposition is hereditary and relevant to the family, while a somatic test asks which treatment a particular tumour might respond to. Which test is required is determined by the physician according to the individual and the clinical situation.
How Does Genetic Testing Guide Treatment?
Genetic testing can guide treatment in several different ways. The best-known route is that, when a specific genetic change is identified in a tumour, treatments that can target that change may become an option. These approaches, known as targeted therapies, aim to address cancer in a more selective way, and their suitability may depend on the genetic profile involved.
Genetic tests can also, in some cases, contribute to shaping the treatment plan by providing information about the possible course of the disease. Hereditary tests, meanwhile, can both influence a person’s own treatment and be important for risk assessment and follow-up among family members. However, the critical point here is this: identifying a genetic change does not always translate directly into a treatment decision; what a result indicates about treatment is interpreted alongside the clinical context and through specialist assessment. This interpretation is carried out by the treating physician and, where necessary, genetic specialists.
The Role of Genetic Counselling
Genetic counselling is an important part of the process, particularly when hereditary genetic testing is involved. Because identifying a hereditary change may concern not only the individual but also family members, it is essential that the meaning of these results is communicated accurately. Genetic counselling helps ensure this information is understood and assessed correctly, both before and after testing.
This process shows that testing is not simply about carrying out the test itself; interpreting the results in light of the individual’s and family’s situation is just as important as the test. In which circumstances genetic testing and counselling are appropriate requires an individual assessment. This article is intended for general informational purposes; the need for genetic testing and counselling can only be determined by a physician and relevant specialists.
Frequently Asked Questions
Is genetic testing in cancer the same as hereditary testing? Not exactly. “Genetic testing” is an umbrella term that includes different types, such as hereditary (germline) and tumour (somatic) tests. Hereditary testing examines inherited predispositions, while tumour testing examines changes specific to the cancer cell. The two serve different purposes, and which one is needed is specific to the individual.
Is genetic testing carried out for every cancer patient? No. Whether genetic testing is needed depends on the type of cancer, the clinical situation, and individual factors. It is not applied in the same way for every patient or every type of cancer. Which test is carried out, and for what purpose, is determined solely through physician assessment.
Does a genetic test result always change treatment? No, not always. Identifying a genetic change does not always translate directly into a treatment decision; what the result indicates about treatment is interpreted alongside the clinical context. This interpretation requires specialist expertise and is carried out by the treating physician.
If a hereditary change is found, does it affect my family too? A hereditary (germline) change is present in all of a person’s cells, so it can also be relevant to family members. For this reason, it is important that hereditary test results are assessed together with genetic counselling. Decisions about family risk assessment and follow-up are individual and are determined by specialists.
Why is genetic counselling important? Genetic counselling helps ensure that the meaning of test results, particularly hereditary results, is communicated accurately and clearly. Because results may concern not only the individual but also the family, correct interpretation is critical. Assessing the results is just as important as the test itself, and this process is carried out by specialists.
Genetic Information Is Interpreted Individually
Genetic testing in cancer is an important tool of modern, personalised oncology, examining hereditary predispositions and tumour-specific changes to help guide treatment. The key principle for understanding this field is to see genetic testing not as a single thing, but as a whole made up of different types serving different purposes, and to recognise that results only gain meaning through specialist assessment.
This article provides general, health-protective information about genetics and genetic testing in cancer; it does not replace diagnosis, treatment recommendations or clinical examination. For information relating to your personal situation, it is recommended that you consult the physician overseeing your treatment.
